<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Results for Clavarezza, Matteo</title>
    <description>Showing 1 - 12 results of 12</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;author=%22Clavarezza%2C+Matteo%22&amp;type=Author</link>
    <opensearch:totalResults>12</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="%22Clavarezza%2C%20Matteo%22" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Clavarezza%2C+Matteo%22&amp;type=Author"/>
    <atom:link rel="last" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Clavarezza%2C+Matteo%22&amp;type=Author"/>
    <atom:link rel="self" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Clavarezza%2C+Matteo%22&amp;type=Author"/>
    <item>
      <title>Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study</title>
      <pubDate>Sun, 01 Jan 2012 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3433340</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3433340</guid>
      <author>Clavarezza, Matteo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2012</dc:date>
      <dc:creator>Clavarezza, Matteo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study</title>
      <pubDate>Sun, 01 Jan 2012 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3404902</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3404902</guid>
      <author>Gori, Stefania</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2012</dc:date>
      <dc:creator>Gori, Stefania</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study</title>
      <pubDate>Tue, 01 Jan 2013 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3755929</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3755929</guid>
      <author>Clavarezza, Matteo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>Clavarezza, Matteo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study</title>
      <pubDate>Tue, 01 Jan 2013 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3805160</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3805160</guid>
      <author>Clavarezza, Matteo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>Clavarezza, Matteo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>AT-11 FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM</title>
      <pubDate>Wed, 01 Jan 2014 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4217788</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4217788</guid>
      <author>Brandes, Alba A.</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Brandes, Alba A.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>NI-26 COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.</title>
      <pubDate>Wed, 01 Jan 2014 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4218351</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4218351</guid>
      <author>Franceschi, Enrico</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Franceschi, Enrico</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma</title>
      <pubDate>Fri, 01 Jan 2016 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4998997</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4998997</guid>
      <author>Brandes, Alba A.</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2016</dc:date>
      <dc:creator>Brandes, Alba A.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer</title>
      <pubDate>Fri, 01 Jan 2016 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-5143350</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-5143350</guid>
      <author>Campora, Sara</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2016</dc:date>
      <dc:creator>Campora, Sara</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study</title>
      <pubDate>Sun, 01 Jan 2017 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-5589683</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-5589683</guid>
      <author>Brandes, Alba A.</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2017</dc:date>
      <dc:creator>Brandes, Alba A.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients</title>
      <pubDate>Mon, 01 Jan 2018 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6280542</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6280542</guid>
      <author>Petrera, Marilena</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2018</dc:date>
      <dc:creator>Petrera, Marilena</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial</title>
      <pubDate>Tue, 01 Jan 2019 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6613306</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6613306</guid>
      <author>Pietrantonio, Filippo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2019</dc:date>
      <dc:creator>Pietrantonio, Filippo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy</title>
      <pubDate>Tue, 01 Jan 2019 00:39:13 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6864846</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6864846</guid>
      <author>Morano, Federica</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2019</dc:date>
      <dc:creator>Morano, Federica</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
